Mathematical models of therapeutical actions related to tumour and immune system competition

Mathematical Methods in the Applied Sciences

Volumn 28, Issue 17, 2005, Pages 2061-2083

  De Angelis, Elena ^a   Jabin, Pierre Emmanuel ^b  

^a POLITECNICO DI TORINO   (Italy)

^b ÉCOLE NORMALE SUPÉRIEURE   (France)

Author keywords

Cauchy problem; Cell population; Tumour immune competition; Vlasov kinetic theory

Indexed keywords

ASYMPTOTIC STABILITY; CELLS; IDENTIFICATION (CONTROL SYSTEMS); IMMUNOLOGY; MATHEMATICAL MODELS; PROBLEM SOLVING;

CAUCHY PROBLEM; CELL POPULATION; TUMOR IMMUNE COMPETITION; VLASOV KINETIC THEORY;

TUMORS;

EID: 27744605399     PISSN: 01704214     EISSN: None     Source Type: Journal    
DOI: 10.1002/mma.656     Document Type: Article

References (16)

1. Bellomo N, Bellouquid A, Delitala M. Mathematical topics on the modelling complex multicellular systems and tumour immune cells competition. Mathematical Models and Methods in Applied Sciences 2004; 14:1683-1733.
2. Bellomo N, De Angelis E, Preziosi L. Multiscale modeling and mathematical problems related to tumour evolution and medical therapy. Journal of Theoretical Medicine 2003; 5:111-136.
3. Arlotti L, Bellomo N, De Angelis E. Generalized kinetic (Boltzmann) models: mathematical structures and applications. Mathematical Models and Methods in Applied Sciences 2002; 12:567-591.
4. Greller L, Tobin F, Poste G. Tumor heterogeneity and progression: conceptual foundation for modeling. Invasion and Metastasis 1996; 16:177-208.
5. Hartwell HL, Hopfield JJ, Leibner S, Murray AW. From molecular to modular cell biology. Nature 1999; 402:c47-c52.
6. De Angelis E, Mesin L. Modelling of the immune response: conceptual frameworks and applications. Mathematical Models and Methods in Applied Sciences 2001; 11:1609-1630.
7. De Angelis E, Jabin PE. Qualitative analysis of a mean field model of tumour-immune system competition. Mathematical Models and Methods in Applied Sciences 2003; 13:187-206.
8. Lollini PL, Forni G. Antitumour vaccines: is it possible to prevent a tumour? Cancer Immunology Immunotherapy 2002; 51:409-416.
9. Folkman J. Angiogenesis. In Harrison's Principle of International Medicine, Braunwald E et al. (eds). McGraw-Hill: New York, 2001; 517-530.
10. Folkman J, Kerbel K. Clinical translation of angiogenesis inhibitors. Nature Reviews Cancer 2002; 2:727-739.
11. Delves PJ, Roitt YM. The immune system. Advances in Immunology 2000; 343:37-49.
12. Derbel L. Analysis of a new model for tumor-immune system competition including long time scale effects. Mathematical Models and Methods in Applied Sciences 2004; 14:1657-1681.
13. Forni G et al. Combined allogeneic tumour cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice. Journal of Experimental Medicine 2001; 194:1195-1206.
14. Dredge K et al. Adjuvant and the promo immunotherapy. Cancer Immunology Immunotherapy 2002; 51:521-531.
15. Nani F, Freedman HI. A mathematical model of cancer treatment by immunotherapy. Mathematical Biosciences 2000; 163:159-199.
16. Jain RK. Molecular regulation of vessel maturation. Nature Medicine 2003; 9:685-693.